PRESS RELEASE published on 10/17/2024 at 07:00, 2 years ago Nine-month results in line with expectations: sales revenue almost at prior-year level; orders on the rise; robust profitability; increased cash flow Sartorius AG reports nine-month results: stable sales revenue, increased orders, strong profitability, and improved cash flow. Full-year outlook confirmed Profitability Sales Revenue Sartorius AG Orders Nine-month Results
BRIEF published on 07/18/2024 at 18:33, 2 years 3 months ago Sartorius AG annonce des performances semestrielles mitigées dans un marché volatil Résultats Semestriels Perspectives 2024 Volatilité Du Marché Sartorius SA Développement Des Revenus
BRIEF published on 07/18/2024 at 18:33, 2 years 3 months ago Sartorius AG Reports Mixed Half-Year Performance Amid Volatile Market Outlook 2024 Market Volatility Sartorius AG Half-year Results Revenue Development
PRESS RELEASE published on 07/18/2024 at 18:28, 2 years 3 months ago Half-year results: Moderately positive revenue development in the second quarter; demand recovery remains muted, full-year outlook deliberately more cautious; long-term trends remain positive Sartorius AG reports moderately positive revenue development in Q2, cautious full-year outlook due to market volatility. Long-term prospects remain positive Market Volatility Sartorius AG Cautious Outlook Long-term Prospects Revenue Development
BRIEF published on 07/18/2024 at 18:27, 2 years 3 months ago Sartorius AG Adjusts Fiscal Year 2024 Guidance and Reports H1 2024 Results 2024 Guidance Life Science Biopharmaceuticals Sartorius AG H1 Results
BRIEF published on 07/18/2024 at 18:27, 2 years 3 months ago Sartorius AG ajuste ses prévisions pour l'exercice 2024 et publie ses résultats du premier semestre 2024 Produits Biopharmaceutiques Sartorius SA Orientation 2024 Sciences De La Vie Résultats Du Premier Semestre
PRESS RELEASE published on 07/18/2024 at 18:22, 2 years 3 months ago EQS-Adhoc: Sartorius AG adjusts its guidance for fiscal year 2024 and presents results for H1 2024 Sartorius AG adjusts fiscal year 2024 guidance & reports H1 results amid challenging market. Sales revenue down, EBITDA & net profit decline Market Challenges Fiscal Year 2024 Sartorius AG Guidance Adjustment Sales Revenue Decline
Published on 10/30/2026 at 23:35, 16 hours 34 minutes ago Prospect Ridge Announces Closing of Critical Metals Flow-through Unit Private Placement
Published on 10/30/2026 at 23:30, 16 hours 39 minutes ago Revolve Enters into Definitive Agreement to Acquire Three Project, 6 MW Battery Storage Portfolio in Ontario
Published on 10/30/2026 at 20:47, 19 hours 22 minutes ago CoTec Holdings Corp. Comments on Share Trading
Published on 10/30/2026 at 19:00, 21 hours 9 minutes ago Electric Royalties Ltd. Announces Application for Warrant Extension
Published on 10/30/2026 at 15:30, 1 day ago Bluejay Diagnostics Announces 1-for-4 Reverse Stock Split
Published on 10/30/2026 at 22:49, 17 hours 20 minutes ago EQS-Adhoc: STRATEC SELLS LOSS-MAKING BUSINESS, RECOGNIZES IMPAIRMENTS, AND AMENDS GUIDANCE
Published on 10/30/2026 at 18:38, 21 hours 31 minutes ago EQS-Adhoc: Starcom Holding AD publishes Interim Q3 2026 Financial Report
Published on 10/30/2026 at 23:00, 17 hours 9 minutes ago BIOPHYTIS REPORTS FIRST- HALF 2026 RESULTS AND PROVIDES AN UPDATE ON ITS STRATEGY
Published on 10/30/2026 at 23:00, 17 hours 9 minutes ago Biophytis publie les résultats du premier semestre 2026 et fait le point sur sa stratégie